UPDATE 1-Alder BioPharma's migraine drug succeeds in mid-stage study
March 28 (Reuters) - Alder BioPharmaceuticals Inc said its drug to prevent migraines met the main goal in a mid-stage study, the results of which support a quarterly single injection dosing strategy.
No comments:
Post a Comment